10x Genomics, Inc. (TXG)
TXG Stock Price Chart
Explore 10x Genomics, Inc. interactive price chart. Choose custom timeframes to analyze TXG price movements and trends.
TXG Company Profile
Discover essential business fundamentals and corporate details for 10x Genomics, Inc. (TXG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
12 Sept 2019
Employees
1.31K
Website
https://www.10xgenomics.comCEO
Serge Saxonov
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
TXG Financial Timeline
Browse a chronological timeline of 10x Genomics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 12 Jan 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is -$0.27.
Earnings released on 7 Aug 2025
EPS came in at $0.28 surpassing the estimated -$0.35 by +180.00%, while revenue for the quarter reached $172.91M , beating expectations by +23.94%.
Earnings released on 8 May 2025
EPS came in at -$0.36 surpassing the estimated -$0.45 by +20.00%, while revenue for the quarter reached $154.88M , beating expectations by +6.62%.
Earnings released on 12 Feb 2025
EPS came in at -$0.40 falling short of the estimated -$0.29 by -37.93%, while revenue for the quarter reached $165.02M , beating expectations by +0.02%.
Earnings released on 29 Oct 2024
EPS came in at -$0.30 surpassing the estimated -$0.34 by +11.76%, while revenue for the quarter reached $151.65M , missing expectations by -1.09%.
Earnings released on 8 Aug 2024
EPS came in at -$0.32 surpassing the estimated -$0.47 by +31.91%, while revenue for the quarter reached $153.10M , beating expectations by +2.01%.
Earnings released on 30 Apr 2024
EPS came in at -$0.50 falling short of the estimated -$0.46 by -8.70%, while revenue for the quarter reached $141.01M , missing expectations by -0.87%.
Earnings released on 15 Feb 2024
EPS came in at -$0.41 falling short of the estimated -$0.36 by -13.89%, while revenue for the quarter reached $183.98M , beating expectations by +0.64%.
Earnings released on 2 Nov 2023
EPS came in at -$0.51 falling short of the estimated -$0.45 by -13.33%, while revenue for the quarter reached $153.64M , beating expectations by +1.58%.
Earnings released on 3 Aug 2023
EPS came in at -$0.53 falling short of the estimated -$0.39 by -35.90%, while revenue for the quarter reached $146.82M , beating expectations by +4.90%.
Earnings released on 3 May 2023
EPS came in at -$0.44 falling short of the estimated -$0.38 by -15.79%, while revenue for the quarter reached $134.29M , missing expectations by -3.22%.
Earnings released on 15 Feb 2023
EPS came in at -$0.15 surpassing the estimated -$0.29 by +48.28%, while revenue for the quarter reached $156.23M , beating expectations by +5.44%.
Earnings released on 2 Nov 2022
EPS came in at -$0.37 surpassing the estimated -$0.45 by +17.78%, while revenue for the quarter reached $131.07M , beating expectations by +1.63%.
Earnings released on 8 Aug 2022
EPS came in at -$0.57 falling short of the estimated -$0.40 by -42.50%, while revenue for the quarter reached $114.61M , missing expectations by -0.95%.
Earnings released on 4 May 2022
EPS came in at -$0.38 falling short of the estimated -$0.37 by -2.70%, while revenue for the quarter reached $114.50M , beating expectations by +1.10%.
Earnings released on 16 Feb 2022
EPS came in at -$0.16 falling short of the estimated -$0.06 by -166.67%, while revenue for the quarter reached $143.53M , missing expectations by -3.37%.
Earnings released on 3 Nov 2021
EPS came in at -$0.15 surpassing the estimated -$0.18 by +16.67%, while revenue for the quarter reached $125.30M , missing expectations by -14.29%.
Earnings released on 4 Aug 2021
EPS came in at -$0.10 surpassing the estimated -$0.26 by +61.54%, while revenue for the quarter reached $115.84M , beating expectations by +2.65%.
Earnings released on 5 May 2021
EPS came in at -$0.11 surpassing the estimated -$0.25 by +56.00%, while revenue for the quarter reached $105.82M , missing expectations by -30.23%.
Earnings released on 17 Feb 2021
EPS came in at -$0.08 surpassing the estimated -$0.28 by +71.43%, while revenue for the quarter reached $112.22M , missing expectations by -92.51%.
Earnings released on 10 Nov 2020
EPS came in at -$0.33 matching the estimated -$0.33, while revenue for the quarter reached $71.82M , beating expectations by +7.74%.
TXG Stock Performance
Access detailed TXG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.